← Leaderboards
Yoseph Barash
University Of Pennsylvania
$7,413,836
Attributed
$10,057,328
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,057,328 · 5
By mechanism
R01$6,519,870 · 4
U01$3,537,458 · 1
Top collaborators
- Nicholas Joseph Hand6 shared
- Andrei Thomas-Tikhonenko3 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Jennifer Kristin Wagner$2,355,244
- Daniel E Polsky$8,806,318
- Emily Largent$3,580,153
- Michael L. Atchison$24,976,166
- Andrei Thomas-Tikhonenko$8,144,872
Others in their field
Top investigators on “Code”
- Christopher McKay · Battelle Memorial Institute$134,148,552
- Katherine M Thibault · Battelle Memorial Institute$134,148,552
- Keiji Fukuda · World Health Organization$128,614,927
- Barbara Driver · Westat, Inc.$95,592,456
- David Heimbrook · Leidos Biomedical Research, Inc.$82,484,202
- David Heymann · World Health Organization$79,613,349
Research focus
CodeVariantGenesData SetCellsRna SplicingMutationTranscriptome SequencingGenetic VariantAffectExonsProtein IsoformsSamplingValidationMapsGenomicsAlternative SplicingEventRna ProcessingComplexCohortBaseTissuesHeritability
Grant awards (23)
Identifying regulatory uORFs as a targetable axis for hereditary disease$404,023
R01 · FY2025 · GM · contact PI
Identifying regulatory uORFs as a targetable axis for hereditary disease$404,023
R01 · FY2024 · GM · contact PI
Identifying regulatory uORFs as a targetable axis for hereditary disease$66,558
R01 · FY2024 · GM · contact PI
Identifying regulatory uORFs as a targetable axis for hereditary disease$404,023
R01 · FY2023 · GM · contact PI
Methods for improving clinical diagnostic by detection, prediction, interpretation and prioritization of aberrant transcriptome variations$339,916
R01 · FY2023 · LM · contact PI
Identifying regulatory uORFs as a targetable axis for hereditary disease$76,447
R01 · FY2023 · GM · contact PI
Cassette exons in neoplastic pro-B-cells: implications for immunotherapy$420,362
U01 · FY2022 · CA
Identifying regulatory uORFs as a targetable axis for hereditary disease$394,453
R01 · FY2022 · GM · contact PI
Methods for improving clinical diagnostic by detection, prediction, interpretation and prioritization of aberrant transcriptome variations$339,881
R01 · FY2022 · LM · contact PI
Methods for RNA splicing variations detection, quantification, visualization, and association from large heterogeneous datasets$432,541
R01 · FY2021 · GM · contact PI
Methods for improving clinical diagnostic by detection, prediction, interpretation and prioritization of aberrant transcriptome variations$346,597
R01 · FY2021 · LM · contact PI
Methods for RNA splicing variations detection, quantification, visualization, and association from large heterogeneous datasets$432,541
R01 · FY2020 · GM · contact PI
Methods for improving clinical diagnostic by detection, prediction, interpretation and prioritization of aberrant transcriptome variations$347,736
R01 · FY2020 · LM · contact PI
Cassette exons in neoplastic pro-B-cells: implications for immunotherapy$185,346
U01 · FY2020 · CA
Methods for RNA splicing variations detection, quantification, visualization, and association from large heterogeneous datasets$432,541
R01 · FY2019 · GM · contact PI
Methods for RNA splicing variations detection, quantification, visualization, and association from large heterogeneous datasets$71,698
R01 · FY2019 · GM · contact PI
Cassette exons in neoplastic pro-B-cells: implications for immunotherapy$2,931,750
U01 · FY2018 · CA
Methods for RNA splicing variations detection, quantification, visualization, and association from large heterogeneous datasets$432,541
R01 · FY2018 · GM · contact PI
Modeling Splicing in normal tissues and neurodegenerative disease$323,005
R01 · FY2018 · AG · contact PI
Modeling Splicing in normal tissues and neurodegenerative disease$323,151
R01 · FY2017 · AG · contact PI
Modeling Splicing in normal tissues and neurodegenerative disease$323,292
R01 · FY2016 · AG · contact PI
Modeling Splicing in normal tissues and neurodegenerative disease$309,681
R01 · FY2015 · AG · contact PI
Modeling Splicing in normal tissues and neurodegenerative disease$315,222
R01 · FY2014 · AG · contact PI